-
Piramal Pharma Solutions wins ‘Industry Partner of the Year’ award
expressbpd
November 09, 2017
Piramal Pharma Solutions (PPS) has been recognised as the ‘Industry Partner of the Year’ at the recently held Global Generics & Biosimilars Awards 2017, in Frankfurt, Germany.
-
Alembic Pharma Q2 net rises to Rs 121 crore
expressbpd
November 09, 2017
Alembic Pharmaceuticals reported a 1.44 per cent increase in consolidated net profit at Rs 121.56 crore for the second quarter ended September 30, mainly on account of decline in total income.
-
Cathay Pacific bags IATA CEIV Pharma Certification
expressbpd
November 09, 2017
Cathay Pacific has become the first airline in Hong Kong, S.A.R., China to be awarded IATA CEIV Pharma Certification, a globally-recognised pharmaceutical product handling accreditation.
-
Abbott pioneered in India Market by launching liquid dosing device
expressbpd
November 09, 2017
The first-of-its-kind device for liquid medicines provides accurate, hygienic and convenient dosing
-
Congress Weighs Repeal of Tax Credit for Rare Disease Drugs
nytimes
November 09, 2017
A decades-old tax credit designed to spur cures for rare diseases has been so successful that it’s now become a target in the House Republican tax plan.
-
Bayer’s Stivarga rejected by NICE for liver cancer
pharmatimes
November 09, 2017
Bayer’s Stivarga is not being recommended by NHS treatment cost regulators for certain patients with advanced unresectable hepatocellular carcinoma.
-
Cellectis reopens the off-the-shelf CAR-T treatment
pharmafile
November 09, 2017
Shares in the company spiked initially on the release of the news, before settling at 30 cents higher than before the announcement.
-
Spark Therapeutics and Pfizer amend license agreement for investigational SPK-9001 in hemophilia B
worldpharmanews
November 09, 2017
Spark Therapeutics (NASDAQ: ONCE) and Pfizer (NYSE: PFE) have amended their license agreement for hemophilia B's investigational gene therapy, SPK-9001
-
Colon cancer breakthrough could lead to prevention - and the foods that can help
worldpharmanews
November 09, 2017
Colon cancer, Crohn's, and other diseases of the gut could be better treated - or even prevented - thanks to a new link between inflammation and a common cellular process, established by the University of Warwick.
-
Tolvaptan identified as a treatment for autosomal dominant polycystic kidney disease
europeanpharmaceuticalreview
November 09, 2017
A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function in patients with polycystic kidney disease…